As New CEO Readies Role, CombiMatrix Posts 51-Percent Rise in Q2 Revenues
August 17, 2010
As New CEO Readies Role, CombiMatrix Posts 51-Percent Rise in Q2 Revenues
The Irvine, Calif.-based firm, which is near completion of its restructuring, brought in total revenues of $916,000 for the three-month period ended June 30, compared to $606,000 for the second quarter of 2009.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - CombiMatrix Cleared to Offer Cyto Array Services to New York State Residents
August 9, 2011 / BioArray News - CombiMatrix Reports Preliminary Annual Growth of 171 Percent for Prenatal Testing Business
January 7, 2013 / GenomeWeb Daily News - CapitalBio Deafness Test Being Evaluated for Neonatal Screening in Three Major Chinese Cities
November 13, 2012 / BioArray News - Array-Based Tests Advance as Dx Firms Engage FDA, Raise Capital, Report Revenue Growth
May 15, 2012 / BioArray News